Sterling M McPherson - JoVE Visualize

Showing results (31-40 of 57) with videos related to

Pageof 6

Sort By:

Drug and Alcohol Dependence|May 24, 2023

Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of healthMengyu Liu, Joel M Caplan, Leslie W Kennedy, et al.

Journal of Addiction Medicine|June 2, 2023

Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use DisorderJulianne D Jett, Gordon Kordas, Sara Parent, et al.

JMIR Formative Research|April 19, 2023

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and AcceptabilityCrystal L Smith, Abigail Keever, Theresa Bowden, et al.

Journal of Ethnicity in Substance Abuse|September 17, 2024

Assessing the validity of the American Indian Enculturation Scale in Alaska Native adults interested in reducing alcohol useJalene L Herron, Alexandra Hernandez-Vallant, Katherine A Hirchak, et al.

Alcohol, Clinical & Experimental Research|February 22, 2023

Validation of the quantification of phosphatidylethanol 16:0/18:1 concentrations in TASSO-M20 devicesJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.

Journal of Diabetes and Its Complications|August 15, 2016

Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney diseaseBrad P Dieter, Sterling M McPherson, Maryam Afkarian, et al.

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 9, 2020

Medication use, renin-angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney diseaseJoshua J Neumiller, Kenn B Daratha, Radica Z Alicic, et al.

Psychiatric Services (Washington, D.C.)|December 19, 2019

Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode PsychosisOladunni Oluwoye, Hailey Reneau, Bryony Stokes, et al.

Experimental and Clinical Psychopharmacology|August 28, 2018

Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal StudySterling M McPherson, Ekaterina Burduli, Crystal Lederhos Smith, et al.

Drug and Alcohol Dependence|February 2, 2024

Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trialSterling M McPherson, Crystal L Smith, Luke Hall, et al.

Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:

Pageof 6

Drug and Alcohol Dependence|May 24, 2023

Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of healthMengyu Liu, Joel M Caplan, Leslie W Kennedy, et al.

Journal of Addiction Medicine|June 2, 2023

Assessing Clinically Significant Cognitive Impairment Using the NIH Toolbox in Individuals with Co-occurring Serious Mental Illness and Alcohol Use DisorderJulianne D Jett, Gordon Kordas, Sara Parent, et al.

JMIR Formative Research|April 19, 2023

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and AcceptabilityCrystal L Smith, Abigail Keever, Theresa Bowden, et al.

Journal of Ethnicity in Substance Abuse|September 17, 2024

Assessing the validity of the American Indian Enculturation Scale in Alaska Native adults interested in reducing alcohol useJalene L Herron, Alexandra Hernandez-Vallant, Katherine A Hirchak, et al.

Alcohol, Clinical & Experimental Research|February 22, 2023

Validation of the quantification of phosphatidylethanol 16:0/18:1 concentrations in TASSO-M20 devicesJulianne D Jett, Rachael Beck, Diana Tyutyunnyk, et al.

Journal of Diabetes and Its Complications|August 15, 2016

Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney diseaseBrad P Dieter, Sterling M McPherson, Maryam Afkarian, et al.

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 9, 2020

Medication use, renin-angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney diseaseJoshua J Neumiller, Kenn B Daratha, Radica Z Alicic, et al.

Psychiatric Services (Washington, D.C.)|December 19, 2019

Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode PsychosisOladunni Oluwoye, Hailey Reneau, Bryony Stokes, et al.

Experimental and Clinical Psychopharmacology|August 28, 2018

Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal StudySterling M McPherson, Ekaterina Burduli, Crystal Lederhos Smith, et al.

Drug and Alcohol Dependence|February 2, 2024

Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trialSterling M McPherson, Crystal L Smith, Luke Hall, et al.

Pageof 6